Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750619 · ClinicalTrials.gov registry record
Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions
A clinical trial of Gastrointestinal Neoplasms and Benign Neoplasm of Intestinal Tract, sponsored by California Pacific Medical Center Research Institute.
- Recruiting
- Registry status
- 8,000
- Enrollment target
- 1
- Study location
NCT01750619: Recruiting study of Gastrointestinal Neoplasms and Benign Neoplasm of Intestinal Tract, sponsored by California Pacific Medical Center Research Institute.
NCT01750619 is a study of Gastrointestinal Neoplasms and Benign Neoplasm of Intestinal Tract that is actively recruiting participants, run by California Pacific Medical Center Research Institute. The registered enrollment target is 8,000 participants, above the 300-participant average among 12 other Gastrointestinal Neoplasms trials with a reported enrollment target (2567% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01750619, a study of Gastrointestinal Neoplasms and Benign Neoplasm of Intestinal Tract, is actively recruiting participants, sponsored by California Pacific Medical Center Research Institute.
- RECRUITING
- Registry status
- 8,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.
Primary Outcome
Technical success is defined as complete resection confirmed by the endoscopic absence of adenomatous tissue after inspection with high-definition white light and narrow-band imaging.
Conditions Studied
Study Locations (1)
California
- Interventional Endoscopy Services - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2011-07 |
| Est. Completion | 2030-12 |
What NCT01750619 shows while recruiting
NCT01750619 is an observational study that tracks outcomes without assigning an intervention. Its 8,000 participants enrollment target places it among the larger protocols in the corpus, above the 300-participant average among 12 other Gastrointestinal Neoplasms trials with a reported enrollment target (2567% higher).
The record links to 2 conditions, with Gastrointestinal Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT01750619 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01750619 about?
NCT01750619 is a clinical study titled "Clinical Outcomes of the Endoscopic Resection of Premalignant and Malignant Gastrointestinal Lesions". To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resecti...
What is the current status of trial NCT01750619?
This trial is currently recruiting. The enrollment target is 8,000 participants. The study started on 2011-07. Estimated completion is 2030-12.
What conditions does trial NCT01750619 study?
This clinical trial studies the following conditions: Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract.
Who is sponsoring clinical trial NCT01750619?
This trial is sponsored by California Pacific Medical Center Research Institute, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01750619 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01750619's enrollment target sits among peer trials
8,000 1st of 12 higher than 12 of 12 other Gastrointestinal Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastrointestinal Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
RECRUITING · Phase 1
-
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RECRUITING · Phase 3
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RECRUITING · Phase 3
-
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
RECRUITING · Phase 1
-
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia